At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 4, 2026 at 08:00 ET
CytomX Therapeutics announced it will report full year 2025 financial results on March 16, 2026, before markets open, followed by a conference call. The press release contains no financial data, forward-looking results, or operational updates beyond the announcement of the earnings event.
- CytomX Therapeutics (CTMX) will report full year 2025 financial results on March 16, 2026, before market open.
- Company will host a conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT on the same day.
- No financial results, guidance, or material operational updates were disclosed in this press release.
- The release serves solely as a scheduling announcement for upcoming earnings.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access